摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8,8-dimethyl-5-(4-nitrophenyl)-8,9-dihydro-1H-chromeno[2,3-d]pyrimidine-2,4,6(3H, 5H,7H)-trione | 1251930-44-5

中文名称
——
中文别名
——
英文名称
8,8-dimethyl-5-(4-nitrophenyl)-8,9-dihydro-1H-chromeno[2,3-d]pyrimidine-2,4,6(3H, 5H,7H)-trione
英文别名
8,9-dihydro-8,8-dimethyl-5-(4-nitrophenyl)-1H-chromeno[2,3-d]pyrimidine2,4,6(3H,5H,7H)-trione;8,8-Dimethyl-5-(4-nitrophenyl)-1,5,7,9-tetrahydrochromeno[2,3-d]pyrimidine-2,4,6-trione
8,8-dimethyl-5-(4-nitrophenyl)-8,9-dihydro-1H-chromeno[2,3-d]pyrimidine-2,4,6(3H, 5H,7H)-trione化学式
CAS
1251930-44-5
化学式
C19H17N3O6
mdl
——
分子量
383.36
InChiKey
HQAFUTGBOULSJD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    28
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    130
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    巴比妥酸对硝基苯甲醛5,5-二甲基-1,3-环己二酮四丁基碘化铵 作用下, 以 为溶剂, 以86%的产率得到8,8-dimethyl-5-(4-nitrophenyl)-8,9-dihydro-1H-chromeno[2,3-d]pyrimidine-2,4,6(3H, 5H,7H)-trione
    参考文献:
    名称:
    一锅三组分合成铬诺[2,3-d]嘧啶衍生物:新颖,简单,有效的电化学方法
    摘要:
    一种原子经济,选择性和方便的单罐操作规程,可用于合成具有医学优势的新型chromeno [2,3- d ]嘧啶支架,即巴比妥酸衍生物,1,3环二酮和各种醛的多组分反应据报道,室温下水介质中存在四正丁基碘化铵(TBAI)作为电解质。这种具有生态学意义的新颖概念提供了对环境无害的合成路线,较短的反应时间和简便的后处理步骤,且收率极高(88%至90%),并且还有利于面向多样性的大规模流程。通过IR,MS,NMR和CHN分析对合成产物进行表征。
    DOI:
    10.1002/jhet.3741
点击查看最新优质反应信息

文献信息

  • Sc(OTf)<sub>3</sub>catalysed multicomponent synthesis of chromeno[2,3-<i>d</i>]pyrimidinetriones under solvent-free condition
    作者:Savita Kumari、Dhirendra Kumar、Somaiah Gajaganti、Vandana Srivastava、Sundaram Singh
    DOI:10.1080/00397911.2018.1560471
    日期:2019.2.1
    Abstract An efficient, simple, and environmentally friendly synthesis of a series of chromeno[2,3-d]pyrimidine-trione derivatives has been accomplished via the three-component reaction of a barbituric acid, dimedone/cyclohexane-1,3-dione, and aromatic aldehydes using Sc(OTf)3 as a recyclable catalyst under solvent-free condition. This method exploits the use of Sc(OTf)3 as a Lewis acid catalyst in
    摘要 通过巴比妥酸二甲酮/环己烷-1,3-二酮的三组分反应,高效、简单、环保地合成了一系列色基[2,3-d]嘧啶-三酮衍生物,在无溶剂条件下,使用 Sc(OTf)3 作为可回收催化剂的芳香醛。该方法利用 Sc(OTf)3 作为有机合成中的路易斯酸催化剂,并提供许多奖励,例如出色的产品收率和简单的后处理程序。无害的反应条件,以及没有副产品,是该协议的另一个绿色方面。图形概要
  • Chromeno[2,3-d]pyrimidine-triones Synthesis by a Three-Component Coupling Reaction
    作者:Ramin Ghahremanzadeh、Fatemeh Fereshtehnejad、Ayoob Bazgir
    DOI:10.1248/cpb.58.516
    日期:——
    A simple and one-pot synthesis of new chromeno[2,3-d]pyrimidine-triones by a three-component condensation reaction of barbituric acids, aldehydes and cyclohexane-1,3-diones in refluxing ethanol in the presence of p-toluenesulfonic acid (p-TSA) for 3—10 h is reported. Two cyclohexane-1,3-diones, four barbituric acids and six substituted aldehydes were chosen for the library validation. Prominent among the advantages of this new method are operational simplicity, good yields and easy work-up procedures employed.
    报道了一种简单的一锅法合成新型色酸[2,3-d]嘧啶三酮的三组分缩合反应,反应底物为巴比妥酸、醛和环己烯-1,3-二酮,在回流的乙醇中存在对甲苯磺酸(p-TSA)的条件下进行,反应时间为3到10小时。选择了两种环己烯-1,3-二酮、四种巴比妥酸和六种取代醛进行库的验证。该新方法的主要优点包括操作简单、产率良好和易于后续处理的程序。
查看更多

同类化合物

叔-丁基2-(甲磺酰)-5,7-二氢螺[吡喃并[4,3-D]嘧啶并-8,3-吡咯烷]-1-甲酸基酯 乙基7'-氨基-6-氟-2,2',4'-三羰基-1,1',2,2',3',4'-六氢螺[吲哚-3,5'-吡喃并[2,3-d]嘧啶]-6'-羧酸酯 7H-吡喃并[2,3-d]嘧啶-7-酮 7H-吡喃并[2,3-d]嘧啶 7,8-二氢-5H-吡喃并[4,3-D]嘧啶-2-胺 5H-吡喃并[4,3-d]嘧啶 5H-吡喃并[2,3-d]嘧啶 2H-吡喃并[2,3-d]嘧啶-6-甲腈,7-氨基-1,3,4,5-四氢-5-(4-甲氧苯基)-2,4-二羰基- 2,4-二氯-7,8-二氢-5H-吡喃[4,3-d]嘧啶 1H-吡喃并[3,4-d]嘧啶 1H-吡喃并[3,2-d]嘧啶 (5S,7R,8S)-2-methylsulfanyl-5,8-dihydro-7-allyloxymethyl-5-methoxy-pyrano[3,4-d]-pyrimidin-8-ol 5-ethyl-2-[(Z)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-ethyl-2-[[1-(3-methylbutanoyl)piperidin-4-ylidene]amino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 5-butyl-2-[(E)-1-(4-cyclohexylpiperazin-1-yl)butylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione 2,3,3a,9-tetrahydro-5-iodo-2,3,3-trimethylimidazo[5,1-b][1,3]benzoxazin-1-one 2,4-dimethyl-9-methoxy-4,12b-dihydro-1H,7H-chromeno[4',3'-4,5]pyrano[2,3-d]pyrimidine-1,3(2H)-dione 5-methyl-3-{3-[(R)-2-oxo-3-(3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)-oxazolidin-5-yl]-propyl}-1H-quinazoline-2,4-dione 7-amino-2-(benzothiazol-2-ylmethyl)-9-phenylthiazolo[4',5':6,5]pyrano[2,3-d]pyrimidine-8(7H)-one 2-[6-[(2-chlorophenyl)methyl]pyridin-2-yl]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidine 8-amino-2-(methylthio)-5-oxo-6-(pyridin-4-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 5-(4-chlorophenyl)-1,3,8,8-tetramethyl-7,9-dihydro-5H-chromeno[2,3-d]pyrimidine-2,4,6-trione ethyl 7'-amino-2,4'-dioxo-2'-thioxo-1,1',2,2',3',4'-hexahydrospiroindole-3,5'-pyrano[2,3-d]pyrimidine-6'-carboxylate 8-amino-2-(methylthio)-5-oxo-6-(pyridin-3-yl)-5,6-dihydro-4H-pyrano[2,3-d][1,3]thiazolo[4,5-b]pyridine-7-carbonitrile 7-Amino-4-oxo-5-phenyl-2-thioxo-1,3,4,5-tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carboxylic acid ethyl ester 3-(1H-benzoimidazol-2-yl)-3-butyl-5-methyl-dihydro-furan-2-one 3-(1H-benzoimidazol-2-yl)-3-(2-diethylamino-ethyl)-5-methyl-dihydro-furan-2-one 1-{4-[(1R,9S)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea (S)-6-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyridin-2(1H)-one 3-(1H-benzoimidazol-2-yl)-5-methyl-3-(3-methyl-butyl)-dihydro-furan-2-one 13-(3,4-dimethoxyphenyl)-5,5-dimethyl-2-thioxo-2,5,6,8,9,13-hexahydro-4H-pyrimido[5',4':6,7][1,8]naphthyridino[4,3,2-de]quinazoline-10,12(3a1H,11H)-dione (S)-3-allyl-8-ethyl-4,7-dioxo-2-(phenylcarbamoyl)-4,5,7,8-tetrahydro-3H-pyrano[4,3-d]pyrimidin-8-yl acetate 8-{[(2-bromo-3-methylphenyl)oxy]methyl}-1,3-dimethyl-2,3,4,6-tetrahydro-1H-pyrano[3,2-d]pyrimidine-2,4-dione 9-ethyl-6a-methyl-2-phenyl-8,9-dihydro-oxazolo[2,3-b]pyrimido[4,5-d][1,3]oxazin-5-one (S)-1-cyclobutyl-3-(4-(4-(3-methylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenyl)urea (S)-2-(4-(4-(3-ethylmorpholino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)phenylamino)pyrimidin-4(3H)-one (6aRS,10aRS)-4,6,6a,7,8,9,10,10a-octahydro-2,4,6,6-tetramethyl-1H-<2>benzopyrano<3,4-d>pyrimidine-1,3(2H)-dione 5-ethyl-2-[(E)-1-thiophen-3-ylpentylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione N3-(methyl 4-deoxy-α-L-threo-hex-4-enopyranosyluronate)-5-fluorouracil 1-{4-[(1S,9R)-3-((S)-3-methyl-morpholin-4-yl)-12-oxa-4,6-diaza-tricyclo[7.2.1.0-2,7]dodeca-2(7),3,5-trien-5-yl]-phenyl}-3-oxetan-3-yl-urea 4,5-dimethyl-12-(4-methoxyphenyl)-2-thioxo-2,4a,7,8,9,10,11,12-octahydrodipyrimido[4,5-b;4',5'-f] [1,8]naphthyridine-9,11-dione 2-[4-[2-hydroxyethyl(methyl)amino]-2-methyl-7-oxopyrimido[5,4-b][1,4]oxazin-8-yl]acetonitrile 5-ethyl-2-[(Z)-1-thiophen-2-ylethylideneamino]oxy-3H-pyrano[2,3-d]pyrimidine-4,7-dione